Ontario based Stellar Pharmaceuticals Inc. develops and markets therapeutic products for selected healthcare markets. The company commenced operations in 1996 with its development strategy focused on seeking novel applications for its products in markets where it can demonstrate true cost effective therapeutic  advantages.  Currently the company's focus has been on polysaccharide technology.  Stellar currently has products being marketed in Canada with markets opening in Europe and Latin America for certain products.  In addition the company is continuing discussions for potential strategic partners for its products in other markets,  including the US markets.